Recommended Pages at seekingalpha.com
Oral Rheumatoid Arthritis Market Remains Open As FDA Questions Efficacy Of Pfizer's Pill - Seeking Alpha
seekingalpha.com — “Oral Rheumatoid Arthritis Market Remains Open As FDA Questions Efficacy Of Pfizer's Pill - Seeking Alpha” View full resource at seekingalpha.com
Most Recently Shared on May 9, 2012 at 12:54 pm By:
FDA Questions Efficacy Of Pfizer's Pill Tofacitinib for #Rheumatoid #Arthritis - Seeking Alpha http://t.co/biSi1KKq #rheum
Johnson & Johnson Management Discusses Q1 2012 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com — “Johnson & Johnson Management Discusses Q1 2012 Results - Earnings Call Transcript - Seeking Alpha” View full resource at seekingalpha.com
Most Recently Shared on April 17, 2012 at 7:30 pm By:
Seeking Alpha: Johnson & Johnson Management Discusses Q1 2012 Results Earnings Call Transcript http://t.co/U0wJfTCT
Teva's CEO Present at Barclays Capital Global Healthcare Conference (Transcript) - Seeking Alpha
seekingalpha.com — “Teva's CEO Present at Barclays Capital Global Healthcare Conference (Transcript) - Seeking Alpha” View full resource at seekingalpha.com
Most Recently Shared on March 20, 2012 at 8:11 pm By:
Seeking Alpha: Teva's CEO Present at Barclays Capital Global Healthcare Conference (Transcript) http://t.co/TtFtQQS5
Apple Litigation Marks A New Era Of Expectations For Voice Recognition - Seeking Alpha
seekingalpha.com — “Apple Litigation Marks A New Era Of Expectations For Voice Recognition - Seeking Alpha” View full resource at seekingalpha.com
Most Recently Shared on March 14, 2012 at 4:03 am By:
.@_MattBerry: Apple Litigation Marks a New Era of Expectations for Voice Recognition: http://t.co/kpEdKrNg @OrcaHealth via @SeekingAlpha
Cashing In On Diabetes: Novel Approaches - Seeking Alpha
seekingalpha.com — “Cashing In On Diabetes: Novel Approaches - Seeking Alpha” View full resource at seekingalpha.com
Most Recently Shared on March 7, 2012 at 7:35 pm By:
Seeking Alpha: "Cashing In On Diabetes: Novel Approaches" http://t.co/ocuB3Lnc
Access Pharmaceuticals: a New Player in the Oral Mucositis Market - CVTrader - Seeking Alpha
seekingalpha.com — “Access Pharmaceuticals: a New Player in the Oral Mucositis Market - CVTrader - Seeking Alpha” View full resource at seekingalpha.com
Most Recently Shared on February 7, 2012 at 7:22 pm By:
Novo Nordisk: Increasing Diabetes Rate Should Benefit This Danish Pharmaceutical - Seeking Alpha
seekingalpha.com — “Novo Nordisk: Increasing Diabetes Rate Should Benefit This Danish Pharmaceutical - Seeking Alpha” View full resource at seekingalpha.com
Most Recently Shared on January 13, 2012 at 10:23 pm By:
Seeking Alpha: Novo Nordisk: Increasing Diabetes Rate Should Benefit This Danish Pharmaceutical http://t.co/sc97nif6
Delcath Announces Agreement With the Frankfurt University Hospital for Launch of Hepatic CHEMOSAT Delivery System in Germany - Seeking Alpha
seekingalpha.com — “Delcath Announces Agreement With the Frankfurt University Hospital for Launch of Hepatic CHEMOSAT Delivery System in Germany - Seeking Alpha” View full resource at seekingalpha.com
Most Recently Shared on December 28, 2011 at 7:37 pm By:
Coming soon to Euro hospitals, Chemosaturation for metastatic #melanoma, hope FDA is listening/watching http://t.co/oYLYRy7k
Why Diamond Foods' Late Director Shouldn't Have Been On The Audit Committee - Seeking Alpha
seekingalpha.com — “Why Diamond Foods' Late Director Shouldn't Have Been On The Audit Committee - Seeking Alpha” View full resource at seekingalpha.com
Most Recently Shared on November 28, 2011 at 10:00 pm By:
Interesting...Why Diamond Foods' Late Director Shouldn't Have Been On The Audit Committee - Seeking Alpha http://t.co/byNGIipv
Simon Johnson: 'We Are Looking Straight Into The Face Of A Great Depression' - Seeking Alpha
seekingalpha.com — “Simon Johnson: 'We Are Looking Straight Into The Face Of A Great Depression' - Seeking Alpha” View full resource at seekingalpha.com
Most Recently Shared on November 6, 2011 at 5:09 pm By:
"We are looking straight in to the face of a great depression."... http://t.co/Bn3LWCQF
Eli Lilly Is Overvalued, Pfizer More Attractive - Seeking Alpha
seekingalpha.com — “Eli Lilly Is Overvalued, Pfizer More Attractive - Seeking Alpha” View full resource at seekingalpha.com
Most Recently Shared on October 27, 2011 at 2:47 am By:
Seeking Alpha: Eli Lilly Is Overvalued, Pfizer More Attractive http://t.co/eSbJFWCe
GlaxoSmithKline plc's CEO Discusses Q3 2011 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com — “GlaxoSmithKline plc's CEO Discusses Q3 2011 Results - Earnings Call Transcript - Seeking Alpha” View full resource at seekingalpha.com
Most Recently Shared on October 26, 2011 at 7:50 pm By:
GlaxoSmithKline plc's CEO Discusses Q3 2011 Results - Earnings Call Transcript - Seeking Alpha http://t.co/w3n7KYYb
Stryker's CEO Discusses Q3 2011 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com — “Stryker's CEO Discusses Q3 2011 Results - Earnings Call Transcript - Seeking Alpha” View full resource at seekingalpha.com
Most Recently Shared on October 20, 2011 at 8:50 am By:
Stroke News: Stryker's CEO Discusses Q3 2011 Results - Earnings Call Transcript - Seeking Al... http://t.co/UaDknasi ChicagoEndovascular
Smart Balance's Acquisition Of Glutino Makes The Stock A Buy - Seeking Alpha
seekingalpha.com — “Smart Balance's Acquisition Of Glutino Makes The Stock A Buy - Seeking Alpha” View full resource at seekingalpha.com
Most Recently Shared on October 19, 2011 at 4:31 am By:
Smart Balance's Acquisition Of Glutino Makes The Stock A Buy - Seeking Alpha http://t.co/msHtFC7m #GF #Celiac
Johnson & Johnson Management Discusses Q3 2011 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com — “Johnson & Johnson Management Discusses Q3 2011 Results - Earnings Call Transcript - Seeking Alpha” View full resource at seekingalpha.com
Most Recently Shared on October 18, 2011 at 10:24 pm By:
Endovascular News Johnson & Johnson Management Discusses Q3 2011 Results - Earnings Call Transcript - Seeking Al... http://t.co/Y0SZVhj3

